Miv Therapeutics, Inc. (IVT) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ACCV
2. GMAB
3. IVBIY
4. IIB:IN
5. AZN
6. DRRD:IN
7. SMMT
8. RDY
9. CART
10. CLYM

Go back to Miv Therapeutics, Inc. (IVT) Tops Q2 EPS by 1c

InvenTrust Properties Corp. Reports 2023 Second Quarter Results

July 31, 2023 4:05 PM EDT

DOWNERS GROVE, III.--(BUSINESS WIRE)-- InvenTrust Properties Corp. (InvenTrust or the Company) (NYSE: IVT) today reported financial and operating results for the period ended June 30, 2023. For the three months ended June 30, 2023 and 2022, Net Income was $2.1 million, or $0.03 per diluted share, compared to Net Income of $41.9 million, or $0.62 per diluted share, respectively.

Second Quarter 2023 Highlights:

NAREIT FFO of $0.43 per diluted share Core FFO of $0.43 per diluted share Same Property Net Operating Income (NOI) growth of 3.7% Leased Occupancy as of June 30, 2023... More